Growth Hormone Deficiency in Children Completed Phase 3 Trials for Salicylic acid (DB00936)

IndicationStatusPhase
DBCOND0034025 (Growth Hormone Deficiency in Children)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01502124Safety and Efficacy of Somatropin in Children With Growth Hormone DeficiencyTreatment